First case of Whipple's disease successfully treated with tigecycline.

Tropheryma whipplei treatment Whipple’s disease tigecycline

Journal

Germs
ISSN: 2248-2997
Titre abrégé: Germs
Pays: Romania
ID NLM: 101596099

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 07 01 2020
revised: 09 04 2020
accepted: 13 06 2020
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

Whipple's disease is a rare chronic infectious disease caused by We describe a case of a 42-year-old woman with a history of chronic diarrhea and weight loss evolving for at least the last 6 years. The diagnosis of Whipple's disease was confirmed by histopathological examination of duodenal biopsy samples with Periodic acid-Schiff positive macrophages and by polymerase chain reaction technique detecting the DNA of The intriguing thing with this case was not only the natural resistance to co-trimoxazole but that the infection was controlled empirically with long-lasting i.v. tigecycline since several failed attempts to discontinue i.v. treatment followed. This might be due to erratic absorption of oral drugs due to gut inflammation. To our knowledge, this is the first case of Whipple's disease successfully treated with long-lasting induction parenteral tigecycline followed by p.o. doxycycline along with hydroxychloroquine for one year and after by p.o. doxycycline alone.

Identifiants

pubmed: 33898347
doi: 10.18683/germs.2021.1246
pii: germs.2021.1246
pmc: PMC8057852
doi:

Types de publication

Case Reports

Langues

eng

Pagination

105-110

Informations de copyright

GERMS.

Déclaration de conflit d'intérêts

Conflicts of interest: All authors – none to declare.

Références

Aliment Pharmacol Ther. 2015 Apr;41(8):709-24
pubmed: 25693648
Lancet Infect Dis. 2016 Mar;16(3):e13-22
pubmed: 26856775
Clin Infect Dis. 2008 Sep 1;47(5):659-67
pubmed: 18662136
Lancet Infect Dis. 2008 Mar;8(3):179-90
pubmed: 18291339
Ann Intern Med. 2010 Dec 7;153(11):710-7
pubmed: 21135294
N Engl J Med. 2007 Jan 4;356(1):55-66
pubmed: 17202456
J Antimicrob Chemother. 2010 Sep;65(9):2005-12
pubmed: 20639526
Am J Gastroenterol. 2005 May;100(5):1167-73
pubmed: 15842595
Medicine (Baltimore). 2015 Apr;94(15):e714
pubmed: 25881849
Clin Microbiol Rev. 2017 Apr;30(2):529-555
pubmed: 28298472

Auteurs

Kalliopi Foteinogiannopoulou (K)

MD, Gastroenterology Department, University General Hospital of Heraklion, Voutes, Heraklion, Crete, zip code 71110, Greece.

Ioannis Mouzas (I)

MD, PhD, Gastroenterology Department, University General Hospital of Heraklion, Voutes, Heraklion, Crete, zip code 71110, Greece.

Maria Tzardi (M)

MD, PhD, Pathology Department, University General Hospital of Heraklion, Voutes, Heraklion, Crete, zip code 71110, Greece.

Eleni Orfanoudaki (E)

MD, Gastroenterology Department, University General Hospital of Heraklion, Voutes, Heraklion, Crete, zip code 71110, Greece.

Eirini Theodoraki (E)

MD, Gastroenterology Department, University General Hospital of Heraklion, Voutes, Heraklion, Crete, zip code 71110, Greece.

Diamantis Kofteridis (D)

Internal Medicine Department, University General Hospital of Heraklion, Crete, zip code 71110, Greece.

Classifications MeSH